Gene · 4824
Papers3,429
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,429
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Urothelial Carcinoma Recurrence With an Ileal Conduit: Multimodal Management With Extirpative Surgery, Chemotherapy, and Immunotherapy. | Cureus | 2023 | 38283476 | PubTator, text mining | PubMed |
| Lower percentages of natural killer cells in children with type 1 diabetes and their siblings. | Pediatr Endocrinol Diabetes Metab | 2023 | 38282490 | PubTator, text mining | PubMed |
| Pleomorphic giant cell carcinoma of the prostate: A case report and mini‑review of the literature. | Med Int (Lond) | 2023 | 38222251 | PubTator, text mining | PubMed |
| A Rare Case of Rhabdoid Pancreatic Carcinoma: Prolonged Disease-Free Survival Following Upfront Resection and Adjuvant Chemotherapy. | Cureus | 2023 | 38186431 | PubTator, text mining | PubMed |
| Understanding the role of Pax5 in development of taxane-resistant neuroendocrine like prostate cancers. | Res Sq | 2023 | 38168280 | PubTator, text mining | PubMed |
| Androgen receptor contributes to repairing DNA damage induced by inflammation and oxidative stress in prostate cancer. | Turk J Biol | 2023 | 38155939 | PubTator, text mining | PubMed |
| Clear cell urothelial carcinoma of bladder: Case report of a rare and aggressive variant with review of literature. | Indian J Cancer | 2023 | 38145907 | PubTator, text mining | PubMed |
| Inflammation in Prostate Cancer: Exploring the Promising Role of Phenolic Compounds as an Innovative Therapeutic Approach. | Biomedicines | 2023 | 38137361 | PubTator, text mining | PubMed |
| Protein Kinase CK2α', More than a Backup of CK2α. | Cells | 2023 | 38132153 | PubTator, text mining | PubMed |
| Calcium Activation of the Androgen Receptor in Prostate Cells. | Int J Endocrinol | 2023 | 38131032 | PubTator, text mining | PubMed |
| The role of RNA modification in urological cancers: mechanisms and clinical potential. | Discov Oncol | 2023 | 38117350 | PubTator, text mining | PubMed |
| Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases. | J Immunol Res | 2023 | 38106519 | PubTator, text mining | PubMed |
| Association between copy number alterations estimated using low-pass whole genome sequencing of formalin-fixed paraffin-embedded prostate tumor tissue and cancer-specific clinical parameters. | Sci Rep | 2023 | 38105358 | PubTator, text mining | PubMed |
| Validation of potential RNA biomarkers for prostate cancer diagnosis and monitoring in plasma and urinary extracellular vesicles. | Front Mol Biosci | 2023 | 38099195 | PubTator, text mining | PubMed |
| Diagnostic approach to prevascular (anterior) mediastinal lymphomas: when thoracic pathology meets hematopathology. | Mediastinum | 2023 | 38090035 | PubTator, text mining | PubMed |
| Case report: Squamous cell carcinoma of the prostate-a clinicopathological and genomic sequencing-based investigation. | Pathol Oncol Res | 2023 | 38089646 | PubTator, text mining | PubMed |
| Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways. | J Exp Clin Cancer Res | 2023 | 38087324 | PubTator, text mining | PubMed |
| Therapeutic cancer vaccines: advancements, challenges, and prospects. | Signal Transduct Target Ther | 2023 | 38086815 | PubTator, text mining | PubMed |
| Primary amelanotic malignant melanoma masquerading as adenocarcinoma prostate - A pathological dilemma. | Indian J Urol | 2023 | 38077197 | PubTator, text mining | PubMed |
| An Unusual Case of Metachronous Tumors of Prostate and Parotid Gland: A Diagnostic Dilemma. | Cureus | 2023 | 38074059 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4824/papers?page=11